ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $44,000 | -53.7% | 14,886 | -45.3% | 0.00% | – |
| Q2 2021 | $95,000 | -57.2% | 27,231 | -58.2% | 0.00% | – |
| Q1 2021 | $222,000 | -83.6% | 65,095 | -7.4% | 0.00% | – |
| Q4 2020 | $1,350,000 | +89.9% | 70,320 | +32.8% | 0.00% | – |
| Q3 2020 | $711,000 | -68.8% | 52,957 | -1.6% | 0.00% | -100.0% |
| Q2 2020 | $2,279,000 | +72.9% | 53,812 | +12.7% | 0.00% | – |
| Q1 2020 | $1,318,000 | -18.6% | 47,739 | -4.3% | 0.00% | – |
| Q4 2019 | $1,620,000 | +43.6% | 49,910 | +15.2% | 0.00% | – |
| Q3 2019 | $1,128,000 | +0.2% | 43,312 | +41.2% | 0.00% | – |
| Q2 2019 | $1,126,000 | +120.8% | 30,679 | +33.0% | 0.00% | – |
| Q1 2019 | $510,000 | +54.1% | 23,071 | -1.8% | 0.00% | – |
| Q4 2018 | $331,000 | -79.8% | 23,502 | -72.1% | 0.00% | – |
| Q3 2018 | $1,637,000 | -9.0% | 84,341 | +3.6% | 0.00% | – |
| Q2 2018 | $1,799,000 | +395.6% | 81,426 | +375.7% | 0.00% | – |
| Q1 2018 | $363,000 | – | 17,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $54,146,000 | 10.78% |
| Boxer Capital, LLC | 5,607,086 | $19,569,000 | 0.69% |
| Ikarian Capital, LLC | 1,986,412 | $6,933,000 | 0.56% |
| Samsara BioCapital, LLC | 700,421 | $2,444,000 | 0.30% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,680 | $652,000 | 0.29% |
| EcoR1 Capital, LLC | 831,200 | $2,901,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 113,360 | $396,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 230,794 | $805,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 41,210 | $144,000 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 81,180 | $283,000 | 0.02% |